May Lynn Quan1, Rene S Shumak, Vicky Majpruz, Claire M D Holloway, Frances P O'Malley, Anna M Chiarelli. 1. Foothills Medical Center, University of Calgary, Calgary, Alberta; Cancer Care Ontario; Dalla Lana School of Public Health, University of Toronto; Sunnybrook Health Sciences Centre, University of Toronto; and St Michaels Hospital, University of Toronto, Toronto, Ontario, Canada.
Abstract
PURPOSE: Women with an abnormal screening mammogram should ideally undergo an organized assessment to attain a timely diagnosis. This study evaluated outcomes of women undergoing work-up after abnormal mammogram through a formal breast assessment affiliate (BAA) program with explicit care pathways compared with usual care (UC) using developed quality indicators for screening mammography programs. METHODS: Between January 1 and December 31, 2007, a total of 320,635 women underwent a screening mammogram through the Ontario Breast Screening Program (OBSP), of whom 25,543 had an abnormal result requiring further assessment. Established indicators assessing timeliness, appropriateness of follow-up, and biopsy rates were compared between women who were assessed through either a BAA or UC using χ(2) analysis. RESULTS: Work-up of the abnormal mammogram for patients screened through a BAA resulted in a greater proportion of women attaining a definitive diagnosis within the recommended time interval when a histologic diagnosis was required. In addition, use of other quality measures including specimen radiography for both core biopsies and surgical specimens and preoperative core needle biopsy was greater in BAA facilities. CONCLUSION: These findings support future efforts to increase the number of BAAs within the OBSP, because the pathways and reporting methods associated with them result in improvements in our ability to provide timely and appropriate care for women requiring work-up of an abnormal mammogram.
PURPOSE:Women with an abnormal screening mammogram should ideally undergo an organized assessment to attain a timely diagnosis. This study evaluated outcomes of women undergoing work-up after abnormal mammogram through a formal breast assessment affiliate (BAA) program with explicit care pathways compared with usual care (UC) using developed quality indicators for screening mammography programs. METHODS: Between January 1 and December 31, 2007, a total of 320,635 women underwent a screening mammogram through the Ontario Breast Screening Program (OBSP), of whom 25,543 had an abnormal result requiring further assessment. Established indicators assessing timeliness, appropriateness of follow-up, and biopsy rates were compared between women who were assessed through either a BAA or UC using χ(2) analysis. RESULTS: Work-up of the abnormal mammogram for patients screened through a BAA resulted in a greater proportion of women attaining a definitive diagnosis within the recommended time interval when a histologic diagnosis was required. In addition, use of other quality measures including specimen radiography for both core biopsies and surgical specimens and preoperative core needle biopsy was greater in BAA facilities. CONCLUSION: These findings support future efforts to increase the number of BAAs within the OBSP, because the pathways and reporting methods associated with them result in improvements in our ability to provide timely and appropriate care for women requiring work-up of an abnormal mammogram.
Authors: L Tabár; B Vitak; H H Chen; S W Duffy; M F Yen; C F Chiang; U B Krusemo; T Tot; R A Smith Journal: Radiol Clin North Am Date: 2000-07 Impact factor: 2.303
Authors: I A Olivotto; M J Borugian; L Kan; S R Harris; E J Rousseau; S E Thorne; J A Vestrup; C J Wright; A J Coldman; T G Hislop Journal: Can J Public Health Date: 2001 Sep-Oct
Authors: Heidi D Nelson; Kari Tyne; Arpana Naik; Christina Bougatsos; Benjamin K Chan; Linda Humphrey Journal: Ann Intern Med Date: 2009-11-17 Impact factor: 25.391
Authors: Kristina M Blackmore; Ashini Weerasinghe; Claire M B Holloway; Vicky Majpruz; Lucia Mirea; Frances P O'Malley; Cathy Paroschy Harris; Ashley Hendry; Amanda Hey; Anat Kornecki; George Lougheed; Barbara-Anne Maier; Patricia Marchand; David McCready; Carol Rand; Simon Raphael; Roanne Segal-Nadler; Neelu Sehgal; Derek Muradali; Anna M Chiarelli Journal: Can J Public Health Date: 2019-04-29
Authors: Li Jiang; Julie Gilbert; Hugh Langley; Rahim Moineddin; Patti A Groome Journal: Health Promot Chronic Dis Prev Can Date: 2018-10 Impact factor: 3.240
Authors: Anna M Chiarelli; Derek Muradali; Kristina M Blackmore; Courtney R Smith; Lucia Mirea; Vicky Majpruz; Frances P O'Malley; May Lynn Quan; Claire Mb Holloway Journal: Br J Cancer Date: 2017-03-30 Impact factor: 7.640
Authors: Syaribah Noor Brice; Paul Harper; Tom Crosby; Daniel Gartner; Edilson Arruda; Tracey England; Emma Aspland; Kieran Foley Journal: J Health Organ Manag Date: 2021-03-24
Authors: Steven Habbous; Esha Homenauth; Andriana Barisic; Sharmilaa Kandasamy; Vicky Majpruz; Katharina Forster; Marta Yurcan; Anna M Chiarelli; Patti Groome; Claire M B Holloway; Andrea Eisen Journal: CMAJ Open Date: 2022-04-05
Authors: Amalia Plotogea; Anna M Chiarelli; Lucia Mirea; Maegan V Prummel; Nelson Chong; Rene S Shumak; Frances P O'Malley; Claire Mb Holloway Journal: Springerplus Date: 2014-03-06